{"url_path":"/sec/ccrn/10-q/2026/item-3","section_key":"item-3","section_title":"Item 3 QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","accession_number":"0001628280-26-032542","cik":"0001141103","ticker":"CCRN","issuer_name":"CROSS COUNTRY HEALTHCARE INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1141103/0001628280-26-032542-index.html","primary_entity_key":"0001141103","primary_entity_name":"CROSS COUNTRY HEALTHCARE INC"},"word_count":112,"has_tables":true,"body_markdown":"ITEM 3.    QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK\n\nInterest Rate Risk\n\nWe are exposed to variable interest rate risk associated with our Loan Agreement entered into on October 25, 2019. This agreement charges interest at a rate based on either SOFR or Base Rate (as defined in the Loan Agreement) plus an applicable margin.\n\nA 1.0% change in interest rates would have resulted in interest expense fluctuating an immaterial amount for the three months ended March 31, 2026 and 2025, respectively. See Note 8 - Debt to our condensed consolidated financial statements.\n\nOther Risks\n\nThere have been no material changes to our other exposures as disclosed in our 2025 Form 10-K."}